Biotechnology and patentability: navigating unchartered waters in Australia and the US

The debate over the patentability of isolated DNA has raged around the world. Tania Obranovich compares the two Myriad decisions from the highest courts in Australia and the US and explains how the Australian decision has called into question what had long been thought of as a fundamental pillar of Australian patent law
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: